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The  parasite  Fasciola  hepatica  is a major  cause  of  economic  loss to the  agricultural  commu-
nity  worldwide  as  a result  of  morbidity  and  mortality  in livestock,  including  cattle.  Cattle  are
the  principle  reservoir  of verocytotoxigenic  Escherichia  coli O157  (VTEC  O157),  an  impor-
tant  cause  of  disease  in humans.  To  date  there  has been  little  empirical  research  on  the
interaction  between  F.  hepatica  and  VTEC  O157.  It is  hypothesised  that  F. hepatica,  which
is  known  to suppress  type  1  immune  responses  and induce  an  anti-inﬂammatory  or  regu-
latory  immune  environment  in  the  host,  may  promote  colonisation  of  the bovine  intestine
with  VTEC  O157.  Here  we assess  whether  it is statistically  feasible  to  augment  a prospective
study  to quantify  the  prevalence  of  VTEC  O157  in  cattle in Great  Britain  with  a pilot  study
to  test  this  hypothesis.  We  simulate  data  under  the  framework  of a mixed-effects  logistic
regression  model  in  order  to calculate  the  power  to detect  an association  effect  size (odds
ratio) of  2.  In  order  to  reduce  the  resources  required  for  such  a study,  we  exploit  the  fact
that the  test  results  for  VTEC O157  will  be known  in  advance  of testing  for F.  hepatica  by
restricting  analysis  to  farms  with  a VTEC  O157  sample  prevalence  of >0%  and  <100%.
From  a total  of  270 farms  (mean  27 cows  per  farm)  that  will  be  tested  for VTEC  O157,
power  of 87%  can  be  achieved,  whereby  testing  of  F. hepatica  would  only  be necessary  for
an  expected  50  farms,  thus  considerably  reducing  costs. Pre-study  sample  size  calculations
are  an  important  part  of any  study  design.  The  framework  developed  here  is applicable  to
the study  of other  co-infections.
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1. Introduction
Fasciolosis caused by Fasciola hepatica, more commonly
referred to as liver ﬂuke, is a major cause of economic
loss to the agricultural community worldwide as a result
of morbidity and mortality in livestock (Claridge et al.,
2012). Verocytotoxigenic Escherichia coli (VTEC) O157 is a
zoonotic bacteria of worldwide importance which, whilst
largely asymptomatic in cattle, causes haemorrhagic col-
itis and potentially fatal haemolytic uraemic syndrome
in humans as a result of systemic verocytotoxin activity
(Chase-Topping et al., 2008). For both of these pathogens,
cattle are a primary reservoir (Armstrong et al., 1996;
McCann et al., 2010a,b).
To date there has been little empirical research on the
interaction between F. hepatica and VTEC O157 in cat-
tle. Recent evidence suggests a role for type 1 immune
responses in control of VTEC O157 in cattle, with clearance
of the bacteria from the bovine intestine associated with
an up-regulation of T-helper type 1 associated transcripts
within the rectal mucosa, the principle site of colonisation
by this bacteria (Corbishley et al., 2014; Naylor et al., 2003).
On the other hand, F. hepatica is known to suppress type
1 immune responses and induce an anti-inﬂammatory or
regulatory immune environment in the host (Brady et al.,
1999; Flynn et al., 2007). It is of interest to determine if
infection with F. hepatica increases the risk that a cow will
shed VTEC O157, as this will inform future control and risk
management strategies aimed at reducing incidence of dis-
ease in humans.
Before a study with the sole purpose of establishing
whether such an association exists is likely to be funded,
pilot data that can be obtained within existing resource
limitations and logistical constraints are required. A pro-
gramme  of work has been approved by the UK Food
Standards Agency (FSA; Project FS101055), which includes
a survey of VTEC O157 in beef cattle intended for the food
chain in Scotland and in England and Wales. The sampling
protocol for these studies has already been deﬁned and is
based on previously published methods (Gunn et al., 2007;
Pearce et al., 2009). Therefore, the objective of this study is
to establish whether it is feasible to augment the FSA VTEC
O157 study with a pilot study to determine whether shed-
ding of VTEC O157 is independent of F. hepatica infection in
cattle. The statistical framework we have developed here
is applicable to other studies of co-infection.
2. Materials and methods
2.1. Primary study protocol
For the purpose of quantifying the current prevalence
of VTEC O157 across Great Britain, the sampling protocol
developed for two previous surveys will be used (Gunn
et al., 2007; Pearce et al., 2009). Brieﬂy, a sufﬁcient num-
ber of pat samples will be taken from each group of cattle to
ensure 90% probability of detecting shedding of VTEC O157
if at least one shedding animal is present. The aim is to sam-
ple 110 Scottish and 160 English/Welsh farms; only farms
with one or more store/ﬁnishing cattle will be included.
Each farm will be visited on one occasion and visits will be Medicine 119 (2015) 97–104
spread over a 12-month period. Fresh faecal pat samples
will be collected in accordance with the size of the group.
In a previous Wellcome Trust funded International Partner-
ship Research Award in Veterinary Epidemiology (IPRAVE),
a cross-sectional survey of beef cattle was carried out in
Scotland (Pearce et al., 2009), where between 1 and 113
samples were taken per group, with a mean of 27 and a
median of 23 (Chase-Topping, unpublished results).
In the new study, samples from each farm will be sent to
the Epidemiology Research Unit microbiological facilities,
SAC Consulting Veterinary Services Disease Surveillance
Centre, Inverness, within 48 h of collection. Samples of fae-
ces from each pat will be tested for the presence of VTEC
O157 using an immuno-magnetic separation technique as
previously described in (Pearce et al., 2004). The required
amount to fulﬁl the requirements of the FSA project will
be removed and if sufﬁcient sample is available, an aliquot
will be removed and stored at −80 ◦C until the results of the
VTEC O157 tests are known (approximately 1-week). Any
further testing will be subject to the farmer having pro-
vided permission for their samples and data to be used for
purposes other than those of the primary study.
2.2. Secondary study protocol
Following completion of VTEC O157 testing, stored sam-
ples will be made available for ﬂuke testing. Samples will
be transported under Containment Level 3 conditions to
a separate laboratory (Moredun Research Institute, Edin-
burgh) to be tested for F. hepatica using a copro-antigen
detection ELISA (Bio-X Diagnostics, Jemelle, Belgium).
A unique feature of this study is that the presence of
the ﬁrst pathogen (VTEC O157) will be known prior to any
testing for the second pathogen (F. hepatica).
2.3. Statistical analysis
On observing the data, we will ﬁt a mixed effects logistic
regression model. In the absence of data on other explana-
tory variables, this model will be
log
(
pij
1 − pij
)
= ˛j + ˇxij (1)
where
• pij is the probability of cow i on farm j testing positive for
VTEC O157.
• ˛j is the intercept for farm j, such that the ˛j are inde-
pendently distributed according to a normal distribution
with mean  and standard deviation .
• xij = 1 if cow i on farm j tests positive for F. hepatica, and
0 otherwise.
•
 ˇ is the natural log odds ratio (OR) for a positive F. hepatica
test.If data on additional explanatory variables were avail-
able, incorporating these into the statistical model would
potentially reduce the heterogeneity currently captured by
the random effects term, giving rise to a more powerful test
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f the association with liver ﬂuke. The results reported here
an therefore be considered as being conservative.
We exploit the fact that each VTEC O157 test result
ill be known in advance of the samples being requested
or liver ﬂuke testing. If each sample were to be tested at
he same time for both pathogens, then >7000 F. hepat-
ca tests would need to be carried out. As VTEC O157 has
 relatively low prevalence, many farms will have a sam-
le prevalence of 0%. We  expect for this study that these
arms will contribute very little to the estimation of the
odel parameters; therefore we exclude them prior to ﬁt-
ing the regression model. By the same reasoning, some
mall farms with very small sample sizes might also have
 sample prevalence of 100%, and these are also excluded
rior to model ﬁtting. Testing only pat samples from farms
ith a VTEC O157 sample prevalence between >0% and
100% leads to substantial cost-savings, which is the pri-
ary motivation here.
Power is the probability of a test to reject the null
ypothesis when it is false. Conventionally, a test is con-
idered reasonable if its power is >80%. The null hypothesis
n this study is that  ˇ = 0 (i.e. odds ratio = 1). For the cal-
ulations reported here, we assume that a scientiﬁcally
igniﬁcant effect would be that a positive ﬂuke test result
oubles the odds of testing positive for VTEC O157 hence
e set the alternative hypothesis to be  ˇ = log(2).
There is no closed-form solution for the power of the
est, and we therefore use a simulation-based approach
Gelman and Hill, 2007) as follows.
. Simulate a plausible synthetic dataset that adheres to
any known constraints (detailed below) under the alter-
native hypothesis.
. Fit the proposed regression model.
. Test the null hypothesis at the 5% signiﬁcance level.
. Repeat 2500 times and calculate the power as the pro-
portion of simulations where the null hypothesis was
rejected.
For this particular study, before performing step 2 we
ill exclude farms with 0% or 100% VTEC O157 sam-
le prevalence from the synthetic dataset, as described
bove. In what follows, we explore the implications of
andomly sampling M < 270 farms, which, if conferring ade-
uate power, would reduce the necessary resource liability
nd allow for ‘drop outs’ due to inadequate faecal sam-
le amounts or farmers refusing permission for secondary
euse of the samples, which we assume could be treated as
eing non-informative (Little and Rubin, 1987). We would
ote from experience, however, that farmers are generally
eceptive to F. hepatica testing, as it is non-controversial;
herefore refusal for secondary reuse in this context would
e unlikely.
Sensitivity analyses are performed to evaluate the
ependence of statistical power on: (1) the choice of
he alternative hypothesis and (2) the initial prevalence
stimates. We  also illustrate our proposed approach by
imulating one additional dataset and ﬁtting the described
odel.
All analyses are run in R version 3.1.0 (R Foundation for
tatistical Computing, Vienna, Austria). Optimisation and Medicine 119 (2015) 97–104 99
numerical quadrature were performed using base func-
tions ‘uniroot’ and ‘integrate’ respectively. Mixed effects
models are ﬁtted with the lme4 (version 1.1-6) R package
(Bolker et al., 2009). Systems of non-linear equations
were solved using the rootSolve (version 1.6.5) R package
(Soetaert and Herman, 2009). Graphs were produced using
the ggplot2 (version 1.0.0) R package (Wickham, 2009). All
logarithms are to the natural base.
3. Data simulation
As the data have not yet been observed, we must sim-
ulate a plausible synthetic dataset, adhering to constraints
identiﬁed from other available data. To account for the
uncertainty in the data, we simulate multiple datasets.
There are four components to this simulation: (1) the farm-
level sample sizes; (2) the F. hepatica infection; (3) the
farm-level random-effects; and (4) the VTEC O157 infec-
tion.
3.1. Farms
Let Nj be a random variable denoting the sample size
for farm j. To match the proposed study design, the mean
and median sample size should be approximately 27 and
23 cows per farm respectively, with a range of 1–113. We
simulate the number of cows that will be tested in each of
M = 270 farms from a Beta-Binomial model – a generalisa-
tion of the Binomial model that allows for the probability
of the event to be random, and modelled using a Beta
distribution, rather than ﬁxed – thus allowing for over-
dispersion to be incorporated. To achieve this, for each farm
j we  ﬁrst randomly draw qj from a Beta distribution with
shape parameters a = 1.32 and b = 4.35 (see Appendix for
explanation). We  then randomly draw values of Nj − 1 from
a Binomial distribution with size 113 − 1 = 112 and event
probability qj. The Binomial model permits random draws
of 0 (i.e. ‘no events’), whereas the simulation model ensures
that every farm has at least one cow tested.
3.2. F. hepatica infection
Based on existing data, we want the approximate
marginal prevalence of F. hepatica among individual cows
(ignoring clustering effects) to be 20%, and the farm-level
prevalence (the proportion of farms with ≥1 cow testing
positive for F. hepatica) to be 80% (McCann et al., 2010a,b;
Salimi-Bejestani et al., 2005) (http://www.eblex.org.uk/).
To achieve this, within each farm we infect cows with F.
hepatica, in silico, with a within-farm probability rj sampled
from a Beta distribution with shape parameters u = 0.99 and
v = 3.97 (see Appendix for explanation).
3.3. Farm effects and VTEC O157 infection
We  expect VTEC O157 to be clustered within farms,
thus driving heterogeneity. We  simulate farm-level ran-
dom effects ˛j on the logit scale from a normal distribution
with mean  and standard deviation . Based on exist-
ing data, we  want the approximate marginal prevalence
of VTEC O157 among individual cows to be 4%, and the
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or a singFig. 1. Farm-level prevalence distribution for VTEC O157 and F. hepatica f
excluding farms with either 0% or 100% VTEC O157 sample prevalence.
farm-level prevalence (the proportion of farms with ≥1
cow testing positive for VTEC O157) to be 19% (Pearce
et al., 2009). We  determine that this is achieved by select-
ing  = −7.09 and  = 3.52 when  ˇ = log(2) (see Appendix
for explanation). We  then infect each cow i on farm j, in
silico, with probability pij, as deﬁned by Eq. (1).
4. Results
4.1. Power analysis
For each of M = 90, 135, 180, 225 and 270 farms, we
simulated 2500 fake datasets. Fig. 1 summarises a single
simulation of 270 farms. The farm-level and individual-
level infection prevalence ﬁgures are not identical to those
speciﬁed because of random sample variation. We  observe
that a large number of farms have 0% infection for VTEC
O157, and are therefore excluded prior to model ﬁtting.
The simulated datasets satisﬁed the desired attributes on
average, as shown in Fig. 2. Of the 2500 datasets with
270 farms, the mean (standard deviation) of the farm-
level and individual-level sample prevalence for VTEC O157
was 18.9% (2.4%) and 4.0% (1.0%) respectively. Similarly,
for F. hepatica they were 79.9% (2.4%) and 20.0% (1.3%)
respectively. The mean (standard deviation) of the average
number of cows per farm across datasets was 27.1 (1.1) for
the mean, and 23.4 (1.5) for the median.
The power curve is shown in Fig. 3. It shows that from a
synthetic dataset of 270 farms included in the FSA survey,le simulated synthetic dataset of 270 farms. Bottom row shows data after
only 50 farms on average, equating to an average of 1645
pat samples, would have a sample VTEC O157 prevalence
of >0% or <100% and thus require testing for F. hepatica.
This would yield power of 87% to detect an odds ratio of 2,
hence there is potential to test fewer farms. Repeating the
exercise with 225 farms, we  ﬁnd that we expect to apply
ﬂuke testing to 42 farms, equating to approximately 269
fewer pat sample tests, whilst yielding power of 82%.
4.2. Sensitivity analyses
We  simulated 2500 synthetic datasets under alterna-
tive hypothesis effect sizes of  ˇ = log(1.2), log(1.4), . . .,
log(2.0), . . .,  log(3.0), in each case with the maximum num-
ber of farms available for testing (M = 270). In each case we
recalculated the random-effects distribution parameters
to match the marginal VTEC O157 farm-level prevalence.
Power ranged from 13.0% (for OR = 1.2) to 99.6% (for
OR = 3.0) (Fig. 4). The power to detect an OR of 1.8 would
be 75%.
We considered all combinations of the underlying
prevalence values: farm-level VTEC O157 (10% and 25%);
farm-level F. hepatica (70% and 80%); and individual-level
F. hepatica (15% and 25%). The individual-level VTEC O157
prevalence was left unchanged as the theory underlying the
transmission dynamics suggest this value should be stable.
A reduction in the farm-level VTEC O157 was commensu-
rate with a reduction in statistical power, ranging between
54% and 67% for the different F. hepatica prevalence values
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Fig. 2. Distributions of summary statistics calculated for each of 2500 synthetic datasets. Top four panels show the farm-level and individual-level sample
prevalence for VTEC O157 and F. hepatica. The bottom two panels show the distribution of the sample mean and sample median for the number of cows
per  farm. Solid red lines denote the mean of the distribution with dashed red lines denoting ±1 standard deviation. (For interpretation of the references to
color  in this ﬁgure legend, the reader is referred to the web  version of this article.)
Table 1
Sensitivity analysis results showing statistical power for a combination of different underlying prevalence values. The analysis is based on ﬁrst performing
VTEC  O157 testing on all M = 270 farms.
VTEC O157 (farm-level) F. hepatica (farm-level) F. hepatica (individual-level) Power
25% 70% 15% 88.4%
25%  70% 25% 88.8%
25%  85% 15% 93.8%
25%  85% 25% 95.3%
10%  70% 15% 54.0%
c
l
w
O
l
w10%  70% 
10%  85% 
10%  85% 
onsidered (Table 1). Changes in the individual-level preva-
ence for F. hepatica had little effect on the power, except
hen the farm-level prevalence was higher and the VTEC
157 farm-level prevalence low. Increases in the farm-
evel prevalence for F. hepatica were also commensurate
ith increases in statistical power (Table 1).25% 55.3%
15% 60.8%
25% 67.3%
4.3. ExampleWe  generated a single synthetic dataset, summarised in
Fig. 1, representing a total of 7596 cows from 270 farms,
with between 1 and 99 cows sampled from each farm
(mean = 28.0, median = 22.5). The VTEC O157 prevalence
102 G.L. Hickey et al. / Preventive Veterinary Medicine 119 (2015) 97–104
Fig. 3. Power curve to detect an odds ratio of 2 (equivalently  ˇ = log(2)) for a posi
horizontal axis denotes the total number of farms undergoing VTEC O157 testing,
parentheses.
25%
50%
75%
100%
1.5 2.0 2.5 3.0
Odds ratio under alternative hypothesis
Po
w
e
r
Fig. 4. Power curve as a function of the odds ratio (OR) for detection under
the alternative hypothesis. The analysis is based on ﬁrst performing VTEC
in a negligible bias of -0.032, whereas estimation using the
complete dataset had smaller bias (-0.010). In general, theO157 testing on all M = 270 farms.
was 21.9% at the farm-level and 5.5% at the individual-level.
Similarly, F. hepatica prevalence was 81.5% at the farm-
level and 21.3% at the individual-level. A total of 59 farms
had a VTEC O157 prevalence >0% and <100%. Fitting the
above model to these data (Eq. (1)), we estimate the odds
ratio for a positive F. hepatica test result to be 2.36 (95%tive F. hepatica test for varying number of farms available for testing. The
 with the actual number of farms undergoing F. hepatica testing shown in
CI: 1.66-3.37; P < 0.001), in which case we would reject the
null hypothesis of no association of co-infection.
5. Discussion
The design of an experiment should always consider the
number of test samples required. A dedicated stand-alone
study to examine whether there is an association between
the co-infection of F. hepatica and VTEC O571 is probably
not feasible in the absence of any pilot data, as the costs
would be prohibitive. A unique element of the study here
is that the ﬂuke testing is performed post hoc to the primary
FSA funded study, which incorporates the testing of VTEC
O157. The consequence of this is that the desired power
can be achieved whilst reducing the number of samples
that require testing by approximately 80%, thus reducing
the costs.
Trimming the data by excluding farms with either 0%
or 100% sample prevalence for VTEC O157 confers a sub-
stantial reduction in cost but could, in principle, invalidate
the subsequent analysis. For this study we conﬁrmed by
simulation that the analysis gives approximately the cor-
rect signiﬁcance level (between 4.2% and 5.2% of datasets
simulated under the null hypothesis that  ˇ = 0 rejected this
hypothesis at the nominal 5% level). Also, bias in estima-
tion of  ˇ was  small; with 270 farms available for testing
and 2500 simulated synthetic datasets, trimming resultedaccuracy of nominal signiﬁcance levels, and bias in esti-
mation of ˇ, when using our approach will be application
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ependent. We  recommend that users of the approach ver-
fy the properties of the study by simulation using scenarios
ailored to each application.
There are several other limitations to this study. First,
he exact sample sizes of each farm being tested by the FSA
ere unknown during the analysis. By replacing these with
 suitable sampling distribution determined from existing
ata, a decision on the study protocol was possible. How-
ver, farm sizes might have changed over the past decade.
n increase in average farm size will be commensurate
ith an increase in statistical power, but also resource
emands, as it would be expected that there will be fewer
arms with zero VTEC O157 prevalence excluded from the
nalysis. Second, we have assumed that the prevalence
stimates of VTEC O157, which are based on data >10 years
ld, have remained constant at both the individual- and
arm-level, and that the distribution in Scotland is simi-
ar in England and Wales. We  showed that the statistical
ower would be sensitive to a lower farm-level preva-
ence value for VTEC O157, but are otherwise quite robust.
s we randomly simulated datasets, we note that natural
ampling variation in the prevalence values was accounted
or. Thirdly, we ignored farm-level explanatory variables
nd spatiotemporal effects. However, as noted, the addi-
ional adjustment variables would potentially reduce the
tandard error of the effect size estimate; hence the cur-
ent setup should be considered as conservative. Finally,
e have discounted the issue of the test sensitivities and
peciﬁcities, effectively assuming perfect tests (100% sen-
itivity and 100% speciﬁcity for both tests). In practice,
his assumption might not hold and the power calcula-
ions would require further complexity, similar to that
erformed for prevalence estimation using imperfect tests
Diggle, 2011).
Simple formulae are not available for sample size cal-
ulations beyond the most basic of statistical tests. The
ncorporation of random-effects into the model imme-
iately introduces complexity. Simulation-based sample
ize calculations can be tailored to any hypothesised data-
enerating mechanism and analysis protocol where either
ilot data or prevalence estimates are obtainable, and
re therefore applicable to any prospective experimental
esign.
. Conclusions
We  have developed a feasible experimental design to
est whether infection with F. hepatica and VTEC O157 in
attle are independent, which exploits an existing compre-
ensive study and achieves statistical power of 87%. This
tatistical approach might be suitable for other co-infection
tudies.
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Appendix A.
Calculation of Beta distribution shape parameters for
farm sample sizes
We  assume qj is a Beta distributed variable with shape
parameters a and b. Since each farm must have at least
one cow sampled, we  randomly sample Nj − 1 from a
Binomial distribution with size 113 − 1 = 112 and event
probability qj. By ﬁxing the mean of the distribution, which
equals a/(a + b), to be (27 − 1)/112, we obtain the condition
86a = 26b. Furthermore, if we ﬁx the approximate median,
as given by Kerman (2011), to be (23 − 1)/112, we obtain
the condition 90a = 22b + 68/3. Solving this simultaneous
pair of equations admits the solution a = 1.32 and b = 4.35.
Calculation of Beta distribution shape parameters for
F. hepatica infection
Let Xij denote a random variable that equals 1 if cow
i on farm j tests positive for F. hepatica, and 0 otherwise.
Also, let Xj = X1j + X2j + · · · + Xnjj , where nj is the known
total number cows tested on farm j. It is believed that the
individual-level and farm-level F. hepatica prevalence are
approximately 20% and 80% respectively, which is equiv-
alent to P[Xij] = 0.20 and P[Xj > 0] = 0.80. By the law of total
expectation we have, for sufﬁciently large nj:
Er[EX [Xij|rj]] = 0.20 (2)
Er[P[Xj > 0|rj]] = 0.80 (3)
where the outer expectation is taken with respect to a Beta
distributed random variable with shape parameters u and
v. For Eq. (2), the inner expectation reduces to the mean
of a Bernoulli random variable, namely rj, so that the outer
expectation reduces to the expectation of a Beta distributed
random variable, namely u/(u + v). Hence, we  can re-write
the equation as v = 4u. For Eq. (2), we can rewrite the inner
probability as 1 − P[Xj = 0], which is given by 1 − (1 − rj)nj .
Taking the expectation of this term with respect to the
distribution of rj, we  obtain:
1 − 1
B(u, v)
∫ 1
0
ru−1(1 − r)v+nj−1dr = 0.80
which reduces to 5B(u, v + nj) = B(u, v), where B(x, y) is
the Beta function. Combining this with the condition from
Eq. (2), we  obtain the simultaneous condition that 5B(u,
4u + nj) = B(u, 4u), which, conditional on observed nj, can be
solved for u, and subsequently v can be retrieved.
The solution to this system of equations depends on nj.
In general, there are no solutions for this equation for nj < 8,
which is a problem here; however such cases are permissi-
ble in this study. In practice, however, we overcome this by
noting that the constraints only need to hold true on aver-
age.  Therefore we  replace nj with the random variable Nj
(as described earlier) in the equation above, and take the
eterinary
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expectation to obtain:
112∑
x=0
(
112
x
)
B(x + a, 112 − x + b)
B(a, b)
B(u, 4u + x + 1)
= 0.2B(u, 4u)
where a = 1.32 and b = 4.35 are the shape parameters calcu-
lated for sampling from Nj. Hence, the solution, determined
by numerical optimisation, is found to be u = 0.99 and
v = 3.97.
Calculation of random-effects distribution parame-
ters for VTEC O157
Let Yij denote a random variable that equals 1 if cow
i on farm j tests positive for VTEC O157, and 0 otherwise.
Also, let Yj = Y1j + Y2j + · · · + Ynjj , where nj is the total num-
ber cows tested on farm j. Current data suggests that the
marginal individual-level and farm-level VTEC O157 preva-
lence are 4% and 19% respectively, which is equivalent to
P[Yij] = 0.04 and P[Yj > 0] = 0.19. However, each Yij depends
on farm-level random effect, the co-infection effect size
and test result for F. hepatica on the same cow. We  exploit
knowledge about the sampling distribution for the F. hepat-
ica infection, and using Eq. (1), we have, conditional on the
farm-level effects:
EX [EY [Yij|˛j, ˇ, Xij]] = 0.8
(
e˛j
1 + e˛j
)
+ 0.2
(
e˛j+ˇ
1 + e˛j+ˇ
)
EX [EY [P[Yj > 0|˛j, ˇ, Xij]]] = 1 −
[
0.8
(
1
1 + e˛j
)
+ 0.2
(
1
1 + e˛j+ˇ
)  ]nj
(
We  next average each of these over the distribution of
 ˛ ∼ N(, 2). Additionally, as Eq. (4) also depends on nj, we
again average over its sampling distribution to yield:
1 −
112∑
x=0
(
112
x
)
B(x + a, 112 − x + b)
B(a, b)
∫ ∞
−∞
( u|, 2)
×
[
0.8
(
1
1 + e˛j
)
+0.2
(
1
1 + e˛j+ˇ
)]x+1
du
where (u|, 2) is the probability density function
for a normally distributed random variable with mean
 and standard deviation , and the 0.8 and 0.2
multipliers denote P[Xij = 0] and P[Xij = 1] respectively.
Equating these equations to 0.04 and 0.19 respectively,
and solving by numerical integration yields (, ) =
(−7.09, 3.52).
Appendix B. Supplementary dataSupplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.prevetmed.2015.02.022. Medicine 119 (2015) 97–104
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